Antoni Ribas
Director/Board Member at ARCUS BIOSCIENCES, INC.
Net worth: 349 145 $ as of 2024-04-29
Antoni Ribas active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ARCUS BIOSCIENCES, INC. | Director/Board Member | 2019-10-27 | - |
| Independent Dir/Board Member | 2019-10-27 | - | |
| University of California | Corporate Officer/Principal | - | - |
| Jonsson Comprehensive Cancer Center | Corporate Officer/Principal | - | - |
| University of California, Los Angeles | Corporate Officer/Principal | - | - |
Lutris Pharma Ltd.
 Lutris Pharma Ltd. Pharmaceuticals: MajorHealth Technology Lutris Pharma Ltd. is working on the improvement of the anti-cancer therapy effectiveness and the quality of life for patients that are treated with Epidermal Growth Factor Receptor Inhibitors. The company was founded on December 14, 2015 and is headquartered in Tel Aviv, Israel. | Founder | 2015-12-13 | - |
| Chairman | 2022-05-09 | - | |
| Director/Board Member | 2015-12-13 | 2022-05-09 | |
Ysios Capital Partners SGEIC SA
 Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona. | Private Equity Investor | 2020-05-31 | - |
Career history of Antoni Ribas
Former positions of Antoni Ribas
| Companies | Position | Start | End |
|---|---|---|---|
Kalthera, Inc.
 Kalthera, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Immpact Bio USA, Inc., Kalthera, Inc. provides progressive clinical trials services. The company is based in Westlake Village, CA. The company was founded by Yvonne Chen, Cristina Puig Saus, Jim Johnston, Antoni Ribas. Jim Johnston has been the CEO since incorporation. Kalthera was acquired by Immpact Bio USA, Inc. on July 22, 2021. | Founder | 2020-12-31 | 2021-01-01 |
The Parker Institute For Cancer Immunotherapy
 The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky. | Director/Board Member | - | - |
| TANGO THERAPEUTICS, INC. | Founder | 2016-12-31 | - |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | - | - |
| ░░░░ ░░░░░░ ░░░ | ░░░░░░░ | - | - |
| ░░░░░░░░ ░░░░░░░░░░░ ░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | ░░░░░░░░░░ |
| ░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░ | - | - | |
| ░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ | - |
Training of Antoni Ribas
| University of Barcelona | Doctorate Degree |
Statistics
International
| United States | 13 |
| Spain | 3 |
| Israel | 2 |
Operational
| Founder | 7 |
| Director/Board Member | 5 |
| Corporate Officer/Principal | 3 |
Sectoral
| Health Technology | 8 |
| Consumer Services | 4 |
| Commercial Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ARCUS BIOSCIENCES, INC. | Health Technology |
| TANGO THERAPEUTICS, INC. | Health Technology |
| Private companies | 10 |
|---|---|
| Jonsson Comprehensive Cancer Center | |
Tango Therapeutics Sub, Inc.
 Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Health Technology |
PACT Pharma, Inc.
 PACT Pharma, Inc. Pharmaceuticals: MajorHealth Technology PACT Pharma, Inc. develops pharmaceutical products. It offers personalizes adoptive cell therapies with neoantigen-targeted T cells against cancer. The company is headquartered in South San Francisco, CA. | Health Technology |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Commercial Services |
Lutris Pharma Ltd.
Lutris Pharma Ltd. Pharmaceuticals: MajorHealth Technology Lutris Pharma Ltd. is working on the improvement of the anti-cancer therapy effectiveness and the quality of life for patients that are treated with Epidermal Growth Factor Receptor Inhibitors. The company was founded on December 14, 2015 and is headquartered in Tel Aviv, Israel. | Health Technology |
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
Flexus Biosciences, Inc.
 Flexus Biosciences, Inc. BiotechnologyHealth Technology Flexus Biosciences, Inc. provides cancer therapeutics through innovative apps. It engages in leveraging unexploited insights in immunology to discover Agents for Reversal of Tumor Immunosuppression. The company was founded by Terry J. Rosen and Juan C. Jaen in 2013 and is headquartered in San Carlos, CA. | Health Technology |
Ysios Capital Partners SGEIC SA
Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona. | Finance |
The Parker Institute For Cancer Immunotherapy
The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky. | Commercial Services |
Kalthera, Inc.
Kalthera, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Immpact Bio USA, Inc., Kalthera, Inc. provides progressive clinical trials services. The company is based in Westlake Village, CA. The company was founded by Yvonne Chen, Cristina Puig Saus, Jim Johnston, Antoni Ribas. Jim Johnston has been the CEO since incorporation. Kalthera was acquired by Immpact Bio USA, Inc. on July 22, 2021. | Commercial Services |
- Stock Market
- Insiders
- Antoni Ribas
- Experience
